1. Home
  2. CRGO vs ACOG Comparison

CRGO vs ACOG Comparison

Compare CRGO & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

HOLD

Current Price

$2.00

Market Cap

104.9M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$6.10

Market Cap

110.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CRGO
ACOG
Founded
2012
2000
Country
Spain
Canada
Employees
382
57
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
104.9M
110.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CRGO
ACOG
Price
$2.00
$6.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$2.40
$16.00
AVG Volume (30 Days)
89.9K
38.5K
Earning Date
05-26-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.61
$139.22
Revenue Next Year
$16.85
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$4.50
52 Week High
$4.24
$10.88

Technical Indicators

Market Signals
Indicator
CRGO
ACOG
Relative Strength Index (RSI) 58.78 46.61
Support Level $1.96 $5.00
Resistance Level $2.20 $6.59
Average True Range (ATR) 0.12 0.42
MACD -0.01 -0.07
Stochastic Oscillator 64.52 28.62

Price Performance

Historical Comparison
CRGO
ACOG

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters, thousands of forwarders, and dozens of airlines and ocean carriers. The company operates in two segments: the Platform segment and the Solutions segment. The majority of the revenue is derived from the Solutions segment, which provides software tools and data to help industry participants automate their pricing, sales, and procurement processes. Geographically, it generates the maximum revenue from Europe, and the rest from the United States, Hong Kong and Others.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: